Tuesday, January 25, 2022
3:00 PM – 4:00 PM (EST)

No registration is required to participate - the Series is free and open to anyone. To participate, login with your ASCO.org username and password. Click here to create a new, free account or for assistance with your existing login.

Watch Session

 

Dr. George SledgeGeorge W. Sledge Jr., MD, FASCO
Stanford University School of Medicine
Welcome and Introduction
 

Dr. Vicki KeedyVicki L. Keedy, MD, MSCI – Panel Moderator
Vanderbilt University Medical Center

 

Michael C. Heinrich, MD
Oregon Health & Science University
INTRIGUE: A phase III, randomized, open-label study to evaluate the efficacy and safety of ripretinib versus sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib

Dr. George DemetriGeorge D. Demetri, MD
Dana-Farber Cancer Institute
Discussion of Abstract 359881

Panel Question and Answer with Drs. Heinrich and Demetri, Moderated by Dr. Vicki Keedy